Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.

Raphaël Frédérick, Sébastien Blanc, Pierre Larrieu, Laurence Moineaux, Delphine Colette, Graeme Fraser, Vincent Stroobant, Luc Pilotte, Didier Colaux, Johan Wouters, Bernard Masereel, Benoît Van den Eynde, Eduard Dolušić

Research output: Contribution to journalLiterature reviewpeer-review

Original languageFrench
Pages (from-to)181-182
JournalDrugs of the future
Issue numbersuppl A
Publication statusPublished - 2010

Cite this